Biomarkers of aging: From function to molecular biology

Nutrients

Volumn 8, Issue 6, 2016, Pages

  Wagner, Karl Heinz ^a   Cameron Smith, David ^b   Wessner, Barbara ^a   Franzke, Bernhard ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Aging; Biomarker; DNA based marker; Inflammaging; miRNA; Molecular marker; Physical function

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BILIRUBIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; GLUCOSE TRANSPORTER; INSULIN RECEPTOR; LIOTHYRONINE; MICRORNA; SEX HORMONE; THYROTROPIN; THYROXINE; VITAMIN; DNA;

AGING; BODY COMPOSITION; CARDIOVASCULAR FUNCTION; DAILY LIFE ACTIVITY; DNA DAMAGE; DNA REPAIR; ENDOCRINE FUNCTION; ENDOCRINOLOGY; GLUCOSE METABOLISM; HEMATOLOGY; IMMUNITY; INFLAMMATION; LIPID ANALYSIS; MORTALITY; NUTRITIONAL STATUS; PHYSICAL CAPACITY; PHYSICAL PERFORMANCE; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; BLOOD; HUMAN; PHYSIOLOGY;

AGING; BILIRUBIN; BIOMARKERS; DNA; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MICRORNAS;

EID: 84973100058     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8060338     Document Type: Review

References (88)

1. Bratic, A.; Larsson, N. G. The role of mitochondria in aging. J. Clin. Investig. 2013, 123, 951-957. [CrossRef] [PubMed]
2. Kirkwood, T. B. Understanding the odd science of aging. Cell 2005, 120, 437-447. [CrossRef] [PubMed]
3. Franzke, B.; Neubauer, O.; Wagner, K. H. Super dnaging-new insights into DNA integrity, genome stability and telomeres in the oldest old. Mutat. Res. Rev. Mutat. Res. 2015, 766, 48-57. [CrossRef] [PubMed]
4. Lovell, M. A.; Markesbery, W. R. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res. 2007, 35, 7497-7504. [CrossRef] [PubMed]
5. Martin-Ruiz, C.; Dickinson, H. O.; Keys, B.; Rowan, E.; Kenny, R. A.; von Zglinicki, T. Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann. Neurol. 2006, 60, 174-180. [CrossRef] [PubMed]
6. Slijepcevic, P. DNA damage response, telomere maintenance and ageing in light of the integrative model. Mech. Ageing Dev. 2008, 129, 11-16. [CrossRef] [PubMed]
7. Weinert, B. T.; Timiras, P. S. Invited review: Theories of aging. J. Appl. Physiol. 2003, 95, 1706-1716. [CrossRef] [PubMed]
8. Kirkwood, T. B.; Kowald, A. Network theory of aging. Exp. Gerontol. 1997, 32, 395-399. [CrossRef]
9. Borup, M. T.; Trusina, A.; Andersson, A. M. Aging mechanism as the "down side" of adaptation: A network approach. J. Theor. Biol. 2008, 250, 66-74. [CrossRef] [PubMed]
10. Von Zglinicki, T.; Burkle, A.; Kirkwood, T. B. Stress, DNA damage and ageing-An integrative approach. Exp. Gerontol. 2001, 36, 1049-1062. [CrossRef]
11. Cohen, A. A.; Milot, E.; Li, Q.; Bergeron, P.; Poirier, R.; Dusseault-Belanger, F.; Fulop, T.; Leroux, M.; Legault, V.; Metter, E. J.; et al. Detection of a novel, integrative aging process suggests complex physiological integration. PLoS ONE 2015, 10, e0116489. [CrossRef] [PubMed]
12. Arai, Y.; Martin-Ruiz, C. M.; Takayama, M.; Abe, Y.; Takebayashi, T.; Koyasu, S.; Suematsu, M.; Hirose, N.; von Zglinicki, T. Inflammation, but not telomere length, predicts successful ageing at extreme old age: A longitudinal study of semi-supercentenarians. EBioMedicine 2015, 2, 1549-1558. [CrossRef] [PubMed]
13. Hatse, S.; Brouwers, B.; Dalmasso, B.; Laenen, A.; Kenis, C.; Schoffski, P.; Wildiers, H. Circulating micrornas as easy-to-measure aging biomarkers in older breast cancer patients: Correlation with chronological age but not with fitness/frailty status. PLoS ONE 2014, 9, e110644.
14. Burkle, A.; Moreno-Villanueva, M.; Bernhard, J.; Blasco, M.; Zondag, G.; Hoeijmakers, J. H.; Toussaint, O.; Grubeck-Loebenstein, B.; Mocchegiani, E.; Collino, S.; et al. Mark-age biomarkers of ageing. Mech. Ageing Dev. 2015, 151, 2-12. [CrossRef] [PubMed]
15. Johnson, T. E. Recent results: Biomarkers of aging. Exp. Gerontol. 2006, 41, 1243-1246. [CrossRef] [PubMed]
16. Cooper, R.; Kuh, D.; Hardy, R.; Mortality Review Group; FALCon and HALCyon Study Teams. Objectively measured physical capability levels and mortality: Systematic review and meta-analysis. BMJ 2010, 341, c4467. [CrossRef] [PubMed]
17. Ruff, R. M.; Parker, S. B. Gender-and age-specific changes in motor speed and eye-hand coordination in adults: Normative values for the finger tapping and grooved pegboard tests. Percept. Mot. Skills 1993, 76, 1219-1230. [CrossRef] [PubMed]
18. Studenski, S.; Perera, S.; Patel, K.; Rosano, C.; Faulkner, K.; Inzitari, M.; Brach, J.; Chandler, J.; Cawthon, P.; Connor, E. B.; et al. Gait speed and survival in older adults. JAMA 2011, 305, 50-58. [CrossRef] [PubMed]
19. Huang, W. N.; Perera, S.; VanSwearingen, J.; Studenski, S. Performance measures predict onset of activity of daily living difficulty in community-dwelling older adults. J. Am. Geriatr. Soc. 2010, 58, 844-852. [CrossRef] [PubMed]
20. Vermeulen, J.; Neyens, J. C.; van Rossum, E.; Spreeuwenberg, M. D.; deWitte, L. P. Predicting adl disability in community-dwelling elderly people using physical frailty indicators: A systematic review. BMC Geriatr. 2011, 11, 33. [CrossRef] [PubMed]
21. Gobbens, R. J.; van Assen, M. A.; Schalk, M. J. The prediction of disability by self-reported physical frailty components of the tilburg frailty indicator (tfi). Arch. Gerontol. Geriatr. 2014, 59, 280-287. [CrossRef] [PubMed]
22. Martin-Ruiz, C.; Jagger, C.; Kingston, A.; Collerton, J.; Catt, M.; Davies, K.; Dunn, M.; Hilkens, C.; Keavney, B.; Pearce, S. H.; et al. Assessment of a large panel of candidate biomarkers of ageing in the newcastle 85+ study. Mech. Ageing Dev. 2011, 132, 496-502. [CrossRef] [PubMed]
23. Salthouse, T. A. Selective review of cognitive aging. J. Int. Neuropsychol. Soc. 2010, 16, 754-760. [CrossRef] [PubMed]
24. Su, Y. P.; Chang, C. K.; Hayes, R. D.; Perera, G.; Broadbent, M.; To, D.; Hotopf, M.; Stewart, R. Mini-mental state examination as a predictor of mortality among older people referred to secondary mental healthcare. PLoS ONE 2014, 9, e105312. [CrossRef] [PubMed]
25. De Hollander, E. L.; Bemelmans, W. J.; Boshuizen, H. C.; Friedrich, N.; Wallaschofski, H.; Guallar-Castillon, P.; Walter, S.; Zillikens, M. C.; Rosengren, A.; Lissner, L.; et al. The association between waist circumference and risk of mortality considering body mass index in 65-to 74-year-olds: A meta-analysis of 29 cohorts involving more than 58, 000 elderly persons. Int. J. Epidemiol. 2012, 41, 805-817. [CrossRef] [PubMed]
26. Prospective Studies Collaboration; Whitlock, G.; Lewington, S.; Sherliker, P.; Clarke, R.; Emberson, J.; Halsey, J.; Qizilbash, N.; Collins, R.; Peto, R. Body-mass index and cause-specific mortality in 900, 000 adults: Collaborative analyses of 57 prospective studies. Lancet 2009, 373, 1083-1096. [PubMed]
27. Gallucci, M.; Mazzuco, S.; Ongaro, F.; di Giorgi, E.; Mecocci, P.; Cesari, M.; Albani, D.; Forloni, G. L.; Durante, E.; Gajo, G. B.; et al. Body mass index, lifestyles, physical performance and cognitive decline: The "treviso longeva (trelong)" study. J. Nutr. Health Aging 2013, 17, 378-384. [CrossRef] [PubMed]
28. Cruz-Jentoft, A. J.; Baeyens, J. P.; Bauer, J. M.; Boirie, Y.; Cederholm, T.; Landi, F.; Martin, F. C.; Michel, J. P.; Rolland, Y.; Schneider, S. M.; et al. Sarcopenia: European consensus on definition and diagnosis: Report of the european working group on sarcopenia in older people. Age Ageing 2010, 39, 412-423. [CrossRef] [PubMed]
29. Cesari, M.; Fielding, R. A.; Pahor, M.; Goodpaster, B.; Hellerstein, M.; van Kan, G. A.; Anker, S. D.; Rutkove, S.; Vrijbloed, J. W.; Isaac, M.; et al. Biomarkers of sarcopenia in clinical trials-recommendations from the international working group on sarcopenia. J. Cachexia Sarcopenia Muscle 2012, 3, 181-190. [CrossRef] [PubMed]
30. Goodpaster, B. H.; Park, S. W.; Harris, T. B.; Kritchevsky, S. B.; Nevitt, M.; Schwartz, A. V.; Simonsick, E. M.; Tylavsky, F. A.; Visser, M.; Newman, A. B. The loss of skeletal muscle strength, mass, and quality in older adults: The health, aging and body composition study. J. Gerontol. A Biol. Sci. Med. Sci. 2006, 61, 1059-1064. [CrossRef] [PubMed]
31. Visser, M.; Pahor, M.; Tylavsky, F.; Kritchevsky, S. B.; Cauley, J. A.; Newman, A. B.; Blunt, B. A.; Harris, T. B. One-and two-year change in body composition as measured by dxa in a population-based cohort of older men and women. J. Appl. Physiol. 2003, 94, 2368-2374. [CrossRef] [PubMed]
32. Koster, A.; Ding, J.; Stenholm, S.; Caserotti, P.; Houston, D. K.; Nicklas, B. J.; You, T.; Lee, J. S.; Visser, M.; Newman, A. B.; et al. Does the amount of fat mass predict age-related loss of lean mass, muscle strength, and muscle quality in older adults? J. Gerontol. A Biol. Sci. Med. Sci. 2011, 66, 888-895. [CrossRef] [PubMed]
33. Janssen, I.; Heymsfield, S. B.; Ross, R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J. Am. Geriatr. Soc. 2002, 50, 889-896. [CrossRef] [PubMed]
34. Vlachopoulos, C.; Xaplanteris, P.; Aboyans, V.; Brodmann, M.; Cifkova, R.; Cosentino, F.; de Carlo, M.; Gallino, A.; Landmesser, U.; Laurent, S.; et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the european society of cardiology working group on peripheral circulation: Endorsed by the association for research into arterial structure and physiology (artery) society. Atherosclerosis 2015, 241, 507-532. [PubMed]
35. Lewington, S.; Clarke, R.; Qizilbash, N.; Peto, R.; Collins, R.; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360, 1903-1913. [CrossRef]
36. Prospective Studies Collaboration; Lewington, S.; Whitlock, G.; Clarke, R.; Sherliker, P.; Emberson, J.; Halsey, J.; Qizilbash, N.; Peto, R.; Collins, R. Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55, 000 vascular deaths. Lancet 2007, 370, 1829-1839. [PubMed]
37. Briel, M.; Ferreira-Gonzalez, I.; You, J. J.; Karanicolas, P. J.; Akl, E. A.; Wu, P.; Blechacz, B.; Bassler, D.; Wei, X.; Sharman, A.; et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: Systematic review and meta-regression analysis. BMJ 2009, 338, b92. [CrossRef] [PubMed]
38. Sarwar, N.; Danesh, J.; Eiriksdottir, G.; Sigurdsson, G.; Wareham, N.; Bingham, S.; Boekholdt, S. M.; Khaw, K. T.; Gudnason, V. Triglycerides and the risk of coronary heart disease: 10, 158 incident cases among 262, 525 participants in 29 western prospective studies. Circulation 2007, 115, 450-458. [CrossRef] [PubMed]
39. Franceschi, C.; Bonafe, M.; Valensin, S.; Olivieri, F.; de Luca, M.; Ottaviani, E.; de Benedictis, G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000, 908, 244-254. [CrossRef] [PubMed]
40. Visser, M.; Pahor, M.; Taaffe, D. R.; Goodpaster, B. H.; Simonsick, E. M.; Newman, A. B.; Nevitt, M.; Harris, T. B. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: The health abc study. J. Gerontol. A Biol. Sci. Med. Sci. 2002, 57, M326-M332. [CrossRef] [PubMed]
41. Emerging Risk Factors Collaboration; Kaptoge, S.; di Angelantonio, E.; Lowe, G.; Pepys, M. B.; Thompson, S. G.; Collins, R.; Danesh, J. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet 2010, 375, 132-140. [PubMed]
42. Kabagambe, E. K.; Judd, S. E.; Howard, V. J.; Zakai, N. A.; Jenny, N. S.; Hsieh, M.; Warnock, D. G.; Cushman, M. Inflammation biomarkers and risk of all-cause mortality in the reasons for geographic and racial differences in stroke cohort. Am. J. Epidemiol. 2011, 174, 284-292. [CrossRef] [PubMed]
43. Lakoski, S. G.; Le, A. H.; Muntner, P.; Judd, S. E.; Safford, M. M.; Levine, D. A.; Howard, G.; Cushman, M. Adiposity, inflammation, and risk for death in black and white men and women in the United States: The reasons for geographic and racial differences in stroke (regards) study. J. Clin. Endocrinol. Metab. 2011, 96, 1805-1814. [CrossRef] [PubMed]
44. Salvioli, S.; Capri, M.; Bucci, L.; Lanni, C.; Racchi, M.; Uberti, D.; Memo, M.; Mari, D.; Govoni, S.; Franceschi, C. Why do centenarians escape or postpone cancer? The role of igf-1, inflammation and p53. Cancer Immunol. Immunother. 2009, 58, 1909-1917. [CrossRef] [PubMed]
45. International Expert Committee. International expert committee report on the role of the a1c assay in the diagnosis of diabetes. Diabetes Care 2009, 32, 1327-1334.
46. Lobo, R. A. Where are we 10 years after the women's health initiative? J. Clin. Endocrinol. Metab. 2013, 98, 1771-1780. [CrossRef] [PubMed]
47. Cunningham, G. R. Andropause or male menopause? Rationale for testosterone replacement therapy in older men with low testosterone levels. Endocr. Pract. 2013, 19, 847-852. [CrossRef] [PubMed]
48. Junnila, R. K.; List, E. O.; Berryman, D. E.; Murrey, J. W.; Kopchick, J. J. The gh/igf-1 axis in ageing and longevity. Nat. Rev. Endocrinol. 2013, 9, 366-376. [CrossRef] [PubMed]
49. Ouchi, N.; Parker, J. L.; Lugus, J. J.; Walsh, K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11, 85-97. [CrossRef] [PubMed]
50. Poehls, J.; Wassel, C. L.; Harris, T. B.; Havel, P. J.; Swarbrick, M. M.; Cummings, S. R.; Newman, A. B.; Satterfield, S.; Kanaya, A. M. Association of adiponectin with mortality in older adults: The health, aging, and body composition study. Diabetologia 2009, 52, 591-595. [CrossRef] [PubMed]
51. Van den Beld, A. W.; Visser, T. J.; Feelders, R. A.; Grobbee, D. E.; Lamberts, S. W. Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. J. Clin. Endocrinol. Metab. 2005, 90, 6403-6409. [CrossRef] [PubMed]
52. Forestier, E.; Vinzio, S.; Sapin, R.; Schlienger, J. L.; Goichot, B. Increased reverse triiodothyronine is associated with shorter survival in independently-living elderly: The alsanut study. Eur. J. Endocrinol. 2009, 160, 207-214. [CrossRef] [PubMed]
53. Llewellyn, D. J.; Lang, I. A.; Langa, K. M.; Muniz-Terrera, G.; Phillips, C. L.; Cherubini, A.; Ferrucci, L.; Melzer, D. Vitamin D and risk of cognitive decline in elderly persons. Arch. Intern. Med. 2010, 170, 1135-1141. [CrossRef] [PubMed]
54. Kistorp, C.; Raymond, I.; Pedersen, F.; Gustafsson, F.; Faber, J.; Hildebrandt, P. N-terminal pro-brain natriuretic peptide, c-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 2005, 293, 1609-1616. [CrossRef] [PubMed]
55. Frassl, W.; Kowoll, R.; Katz, N.; Speth, M.; Stangl, A.; Brechtel, L.; Joscht, B.; Boldt, L. H.; Meier-Buttermilch, R.; Schlemmer, M.; et al. Cardiac markers bnp, nt-pro-bnp, troponin I, troponin T, in female amateur runners before and up until three days after a marathon. Clin. Lab. 2008, 54, 81-87. [PubMed]
56. Giannoni, A.; Giovannini, S.; Clerico, A. Measurement of circulating concentrations of cardiac troponin I and T in healthy subjects: A tool for monitoring myocardial tissue renewal? Clin. Chem. Lab. Med. 2009, 47, 1167-1177. [CrossRef] [PubMed]
57. Clerico, A.; Fortunato, A.; Ripoli, A.; Prontera, C.; Zucchelli, G. C.; Emdin, M. Distribution of plasma cardiac troponin I values in healthy subjects: Pathophysiological considerations. Clin. Chem. Lab. Med. 2008, 46, 804-808. [CrossRef] [PubMed]
58. Park, D. C.; Yeo, S. G. Aging. Korean J. Audiol. 2013, 17, 39-44. [CrossRef] [PubMed]
59. Hazane, F.; Sauvaigo, S.; Douki, T.; Favier, A.; Beani, J. C. Age-dependent DNA repair and cell cycle distribution of human skin fibroblasts in response to uva irradiation. J. Photochem. Photobiol. B 2006, 82, 214-223. [CrossRef] [PubMed]
60. Fenech, M. Important variables that influence base-line micronucleus frequency in cytokinesis-blocked lymphocytes-a biomarker for DNA damage in human populations. Mutat. Res. 1998, 404, 155-165. [CrossRef]
61. Mullner, E.; Brath, H.; Toferer, D.; Adrigan, S.; Bulla, M. T.; Stieglmayer, R.; Wallner, M.; Marek, R.; Wagner, K. H. Genome damage in peripheral blood lymphocytes of diabetic and non-diabetic individuals after intervention with vegetables and plant oil. Mutagenesis 2013, 28, 205-211. [CrossRef] [PubMed]
62. Fenech, M.; Bonassi, S. The effect of age, gender, diet and lifestyle on DNA damage measured using micronucleus frequency in human peripheral blood lymphocytes. Mutagenesis 2011, 26, 43-49. [CrossRef] [PubMed]
63. Wallner, M.; Blassnigg, S. M.; Marisch, K.; Pappenheim, M. T.; Mullner, E.; Molzer, C.; Nersesyan, A.; Marculescu, R.; Doberer, D.; Knasmuller, S.; et al. Effects of unconjugated bilirubin on chromosomal damage in individuals with gilbert's syndrome measured with the micronucleus cytome assay. Mutagenesis 2012, 27, 731-735. [CrossRef] [PubMed]
64. Franzke, B.; Halper, B.; Hofmann, M.; Oesen, S.; Peherstorfer, H.; Krejci, K.; Koller, B.; Geider, K.; Baierl, A.; Tosevska, A.; et al. The influence of age and aerobic fitness on chromosomal damage in Austrian institutionalised elderly. Mutagenesis 2014, 29, 441-445. [CrossRef] [PubMed]
65. Stewart, J. A.; Chaiken, M. F.; Wang, F.; Price, C. M. Maintaining the end: Roles of telomere proteins in end-protection, telomere replication and length regulation. Mutat. Res. 2012, 730, 12-19. [CrossRef] [PubMed]
66. Sanders, J. L.; Newman, A. B. Telomere length in epidemiology: A biomarker of aging, age-related disease, both, or neither? Epidemiol. Rev. 2013, 35, 112-131. [CrossRef] [PubMed]
67. Rodier, F.; Kim, S. H.; Nijjar, T.; Yaswen, P.; Campisi, J. Cancer and aging: The importance of telomeres in genome maintenance. Int. J. Biochem. Cell Biol. 2005, 37, 977-990. [CrossRef] [PubMed]
68. Garagnani, P.; Giuliani, C.; Pirazzini, C.; Olivieri, F.; Bacalini, M. G.; Ostan, R.; Mari, D.; Passarino, G.; Monti, D.; Bonfigli, A. R.; et al. Centenarians as super-controls to assess the biological relevance of genetic risk factors for common age-related diseases: A proof of principle on type 2 diabetes. Aging 2013, 5, 373-385. [CrossRef] [PubMed]
69. Tedone, E.; Arosio, B.; Gussago, C.; Casati, M.; Ferri, E.; Ogliari, G.; Ronchetti, F.; Porta, A.; Massariello, F.; Nicolini, P.; et al. Leukocyte telomere length and prevalence of age-related diseases in semisupercentenarians, centenarians and centenarians' offspring. Exp. Gerontol. 2014, 58, 90-95. [CrossRef] [PubMed]
70. Chevanne, M.; Calia, C.; Zampieri, M.; Cecchinelli, B.; Caldini, R.; Monti, D.; Bucci, L.; Franceschi, C.; Caiafa, P. Oxidative DNA damage repair and parp 1 and parp 2 expression in epstein-barr virus-immortalized b lymphocyte cells from young subjects, old subjects, and centenarians. Rejuvenation Res. 2007, 10, 191-204. [CrossRef] [PubMed]
71. Wagner, K. H.; Wallner, M.; Molzer, C.; Gazzin, S.; Bulmer, A. C.; Tiribelli, C.; Vitek, L. Looking to the horizon: The role of bilirubin in the development and prevention of age-related chronic diseases. Clin. Sci. 2015, 129, 1-25. [CrossRef] [PubMed]
72. Wallner, M.; Marculescu, R.; Doberer, D.; Wolzt, M.; Wagner, O.; Vitek, L.; Bulmer, A. C.; Wagner, K. H. Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in gilbert's syndrome. Clin. Sci. 2013, 125, 257-264. [CrossRef] [PubMed]
73. Simm, A.; Muller, B.; Nass, N.; Hofmann, B.; Bushnaq, H.; Silber, R. E.; Bartling, B. Protein glycation-Between tissue aging and protection. Exp. Gerontol. 2015, 68, 71-75. [CrossRef] [PubMed]
74. Malavolta, M.; Cipriano, C.; Costarelli, L.; Giacconi, R.; Tesei, S.; Muti, E.; Piacenza, F.; Pierpaoli, S.; Larbi, A.; Pawelec, G.; et al. Metallothionein downregulation in very old age: A phenomenon associated with cellular senescence? Rejuvenation Res. 2008, 11, 455-459. [CrossRef] [PubMed]
75. Sharma, S.; Rais, A.; Sandhu, R.; Nel, W.; Ebadi, M. Clinical significance of metallothioneins in cell therapy and nanomedicine. Int. J. Nanomed. 2013, 8, 1477-1488. [CrossRef] [PubMed]
76. Horvath, S.; Pirazzini, C.; Bacalini, M. G.; Gentilini, D.; di Blasio, A. M.; Delledonne, M.; Mari, D.; Arosio, B.; Monti, D.; Passarino, G.; et al. Decreased epigenetic age of pbmcs from Italian semi-supercentenarians and their offspring. Aging 2015, 7, 1159-1170. [CrossRef] [PubMed]
77. Lowe, D.; Horvath, S.; Raj, K. Epigenetic clock analyses of cellular senescence and ageing. Oncotarget 2016, 7, 8524-8531. [PubMed]
78. Marioni, R. E.; Harris, S. E.; Shah, S.; McRae, A. F.; von Zglinicki, T.; Martin-Ruiz, C.; Wray, N. R.; Visscher, P. M.; Deary, I. J. The epigenetic clock and telomere length are independently associated with chronological age and mortality. Int. J. Epidemiol. 2016. [CrossRef] [PubMed]
79. LaPak, K. M.; Burd, C. E. The molecular balancing act of p16(ink4a) in cancer and aging. Mol. Cancer Res. 2014, 12, 167-183. [CrossRef] [PubMed]
80. Wessner, B.; Gryadunov-Masutti, L.; Tschan, H.; Bachl, N.; Roth, E. Is there a role for micrornas in exercise immunology? A synopsis of current literature and future developments. Exerc. Immunol. Rev. 2010, 16, 22-39. [PubMed]
81. Ibanez-Ventoso, C.; Driscoll, M. Micrornas in C. elegans aging: Molecular insurance for robustness? Curr. Genom. 2009, 10, 144-153. [CrossRef] [PubMed]
82. Inukai, S.; Slack, F. Micrornas and the genetic network in aging. J. Mol. Biol. 2013, 425, 3601-3608. [CrossRef] [PubMed]
83. Keller, A.; Meese, E. Can circulating mirnas live up to the promise of being minimal invasive biomarkers in clinical settings? Wiley Interdiscip. Rev. RNA 2016, 7, 148-156. [CrossRef] [PubMed]
84. McGregor, R. A.; Poppitt, S. D.; Cameron-Smith, D. Role of micrornas in the age-related changes in skeletal muscle and diet or exercise interventions to promote healthy aging in humans. Ageing Res. Rev. 2014, 17, 25-33. [CrossRef] [PubMed]
85. Halper, B.; Hofmann, M.; Oesen, S.; Franzke, B.; Stuparits, P.; Vidotto, C.; Tschan, H.; Bachl, N.; Strasser, E. M.; Quittan, M.; et al. Influence of age and physical fitness on mirna-21, tgf-beta and its receptors in leukocytes of healthy women. Exerc. Immunol. Rev. 2015, 21, 154-163. [PubMed]
86. Olivieri, F.; Bonafe, M.; Spazzafumo, L.; Gobbi, M.; Prattichizzo, F.; Recchioni, R.; Marcheselli, F.; Sala, L. L.; Galeazzi, R.; Rippo, M. R.; et al. Age-and glycemia-related mir-126-3p levels in plasma and endothelial cells. Aging 2014, 6, 771-787. [CrossRef] [PubMed]
87. Mushtaq, G.; Greig, N. H.; Anwar, F.; Zamzami, M. A.; Choudhry, H.; Shaik, M. M.; Tamargo, I. A.; Kamal, M. A. miRNAs as circulating biomarkers for Alzheimer's disease and Parkinson's disease. Med. Chem. 2016, 12, 217-225. [CrossRef] [PubMed]
88. Seeger, T.; Boon, R. A. Micrornas in cardiovascular ageing. J. Physiol. 2015, 594, 2085-2094. [CrossRef] [PubMed]